Journal of Blood Medicine最新文献

筛选
英文 中文
Systematic Literature Review of the Efficacy and Safety of Treatments in Congenital Thrombotic Thrombocytopenic Purpura. 先天性血栓性血小板减少性紫癜治疗的有效性和安全性的系统文献综述。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-10-01 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S599979
Harneet Kaur, Ankit Gupta, Annie Berkley, Inderpreet Singh Khurana
{"title":"Systematic Literature Review of the Efficacy and Safety of Treatments in Congenital Thrombotic Thrombocytopenic Purpura.","authors":"Harneet Kaur, Ankit Gupta, Annie Berkley, Inderpreet Singh Khurana","doi":"10.2147/JBM.S599979","DOIUrl":"https://doi.org/10.2147/JBM.S599979","url":null,"abstract":"<p><strong>Purpose: </strong>Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare, life-threatening thrombotic microangiopathy arising from an inherited deficiency in ADAMTS13 enzyme activity. A systematic literature review was conducted to review and evaluate the clinical efficacy, safety, and tolerability of current and emerging treatments for cTTP.</p><p><strong>Methods: </strong>Literature searches were completed in January 2024. Searches were performed in accordance with PRISMA guidelines to identify studies reporting treatments in patients with cTTP published at any time since database inception. Outcomes of interest included the rates of acute and subacute cTTP events, other disease manifestations, long-term comorbidities, organ damage, mortality, and treatment-related adverse events.</p><p><strong>Results: </strong>Of 3281 records identified, 40 publications reporting results from 20 studies were included. Overall, 16 investigated plasma-based therapies (PBT) alone, and 2 assessed recombinant ADAMTS13 (rADAMTS13) exclusively. The remaining 2 studies compared treatment approaches: PBT versus rADAMTS13, or PBT versus PBT combined with other treatments. Across studies, the mean annual rate of acute cTTP events ranged from 0.05 to 0.55 in adult patients treated with prophylactic PBT and was reported as 0 in patients treated with prophylactic rADAMTS13. All-cause mortality was reported in 5.4% to 10% of patients with cTTP across heterogeneous study populations and follow-up periods. Treatment-related adverse events (TRAEs) were reported in 11.1% to 78% of patients who received prophylactic PBT, reflecting variability in adverse event definitions and reporting, and small sample sizes across studies, which limits direct comparisons between interventions.</p><p><strong>Conclusion: </strong>The available evidence highlights the persistent disease burden of cTTP, with patients experiencing acute events and organ damage despite prophylactic PBT. Further studies are needed to establish the real-world effectiveness of all cTTP treatments, including emerging therapies such as rADAMTS13, that may have the potential to reduce event rates, decrease treatment-related toxicity, and improve long-term outcomes.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"599979"},"PeriodicalIF":2.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13637512/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149109863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective. 将阿西米尼纳入慢性髓性白血病的不断发展的治疗前景:加拿大的观点。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-09-23 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S627651
Dennis Dong Hwan Kim, Lambert Busque, Christopher Hillis, Pierre Laneuville, Mary Lynn Savoie
{"title":"Integrating Asciminib into the Evolving Treatment Landscape of Chronic Myeloid Leukemia: A Canadian Perspective.","authors":"Dennis Dong Hwan Kim, Lambert Busque, Christopher Hillis, Pierre Laneuville, Mary Lynn Savoie","doi":"10.2147/JBM.S627651","DOIUrl":"10.2147/JBM.S627651","url":null,"abstract":"<p><p>Five years after the first readout of the ASCEMBL trial, asciminib evidence has rapidly expanded across the chronic myeloid leukemia (CML) treatment landscape. Subsequent studies and growing real-world experience have also clarified its efficacy and tolerability in earlier treatment lines. As the first allosteric inhibitor targeting the BCR::ABL1 myristoyl pocket, asciminib provides a mechanistically distinct approach that may reduce cross-resistance and toxicity associated with ATP-competitive TKIs. At a time when treatment goals in CML emphasize long-term tolerability, quality of life, and the potential for treatment-free remission (TFR), asciminib's unique molecular and clinical profile justify its inclusion in CML treatment considerations. In this expert opinion review, we synthesize emerging clinical and real-world evidence for asciminib and discuss practical considerations for its integration into contemporary CML management, including its potential im-plications for TFR eligibility. We also explore the role of next-generation sequencing in detecting salvageable resistance mutations, the prognostic significance of co-mutations such as ASXL1, and the concept of mutation-guided treatment sequencing. Collectively, these data position asciminib as an established later-line therapy and an emerging frontline option, with the potential to improve long-term treatment sustainability through favorable tolerability and early molecular response kinetics.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"627651"},"PeriodicalIF":2.1,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacterial Contamination in Stored Blood for Transfusion and Associated Infectious Risks Among Patients with Cancer at Mbarara Regional Referral Hospital, in Uganda. 乌干达姆巴拉拉地区转诊医院储存的输血血液中的细菌污染和癌症患者的相关感染风险
IF 2.1
Journal of Blood Medicine Pub Date : 2026-09-09 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S638289
Ivan Mugisha Taremwa, Scholastic Ashaba, Deusdedit Tusubira, Aggrey Dhabangi, Robert Bortolussi, Noni MacDonald, Lisa M Bebell, Nixon Niyonzima, Bernard Natukunda
{"title":"Bacterial Contamination in Stored Blood for Transfusion and Associated Infectious Risks Among Patients with Cancer at Mbarara Regional Referral Hospital, in Uganda.","authors":"Ivan Mugisha Taremwa, Scholastic Ashaba, Deusdedit Tusubira, Aggrey Dhabangi, Robert Bortolussi, Noni MacDonald, Lisa M Bebell, Nixon Niyonzima, Bernard Natukunda","doi":"10.2147/JBM.S638289","DOIUrl":"10.2147/JBM.S638289","url":null,"abstract":"<p><strong>Background: </strong>Patients with cancer often require supportive transfusion therapy. However, this approach is undermined by the risk of bacterial contamination. This study assessed the bacterial contamination rate, identified the bacterial contaminants and their antimicrobial susceptibility patterns; and the associated infectious risk to patients with cancer at Mbarara Regional Referral Hospital, in southwestern Uganda.</p><p><strong>Materials and methods: </strong>This prospective cohort study used a pre-transfusion aliquot of donor blood or components for blood culture. Positive cultures were identified and their antibiotic susceptibility testing was performed using the bioMerieux VITEK 2 compact system. Recipients were assessed for bacterial infection at 48 hours post-transfusion. Data were analyzed using R software and presented as proportions.</p><p><strong>Results: </strong>We evaluated 376 blood units, with 275 (73.1%) of these being red cell concentrates (RCC). The median storage times for RCC and whole blood (WB) were 23 days (IQR, 18-29 days) and 3 days (IQR, 1-5 days) for platelets (PLT), respectively. Four units (3RCC, 1PLT) had bacterial growth, yielding a contamination rate of 1.1% (95% confidence interval, 0.4-1.8%). <i>Staphylococcus hominis</i> and <i>Bacillus subtlis</i> were isolated from RCC, while <i>Staphylococcus capitis</i> was isolated from PLT. The isolates exhibited variable resistance to erythromycin, clindamycin, teicoplanin, vancomycin, tetracycline, nitrofurantoin, rifampicin, and trimethoprim-sulfamethoxazole. There were 211 recipients whose mean age was 34.1 years (standard deviation: 2.84 years). Of these, 62 (29.4%) had received ≥3 donor units, and 146 had been on antibiotics. None of the investigated recipients had a positive bacterial blood culture.</p><p><strong>Conclusion: </strong>The study found a low bacterial contamination rate of stored blood components underscoring the importance of stringent blood collection precautionary measures. The four bacterial isolates were resistant to common antibiotics, which poses a risk of transmission of antibiotic-resistant strains to immunocompromised recipients with cancer. Notably, there was no infectious risk posed post-transfusion presumably due to the concurrent antibiotic therapy.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"638289"},"PeriodicalIF":2.1,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13571675/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148963193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic Interaction Between PEAR1-FGB and the Dominant Role of ABCB1 in Thrombosis Risk: A SHAP and MDR-Based Study in Vietnamese Pedigrees. PEAR1-FGB和ABCB1在血栓形成风险中的主导作用之间的协同相互作用:一项基于越南家系的SHAP和mdr的研究。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-09-08 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S609149
Hai Bui Hoang, Trang Thi Nguyen, Anh Ngoc Thi Le, Dan Hoang Le, Huy Quang Do, Sang Thanh Nguyen, Ha Thu Thi To, Thuy Thu Thi Nguyen, Hanh Minh Thi Nguyen
{"title":"Synergistic Interaction Between PEAR1-FGB and the Dominant Role of ABCB1 in Thrombosis Risk: A SHAP and MDR-Based Study in Vietnamese Pedigrees.","authors":"Hai Bui Hoang, Trang Thi Nguyen, Anh Ngoc Thi Le, Dan Hoang Le, Huy Quang Do, Sang Thanh Nguyen, Ha Thu Thi To, Thuy Thu Thi Nguyen, Hanh Minh Thi Nguyen","doi":"10.2147/JBM.S609149","DOIUrl":"10.2147/JBM.S609149","url":null,"abstract":"<p><strong>Background: </strong>Thrombosis is a multifactorial disorder with a substantial genetic component, yet gene-gene interactions contributing to thrombotic risk remain insufficiently characterized in Southeast Asian populations. Identifying both individual genetic determinants and interaction effects may improve risk stratification, particularly in families with early-onset thrombotic disease.</p><p><strong>Objective: </strong>This study aimed to explore individual and interactive genetic contributions to thrombotic events in Vietnamese pedigrees with early-onset venous thromboembolism (VTE) using an integrated analytical framework combining Multifactor Dimensionality Reduction (MDR) and SHapley Additive exPlanations (SHAP).</p><p><strong>Methods: </strong>A pedigree-based study was conducted among 88 individuals from families with a history of early-onset VTE (<50 years), including 19 affected cases. Genetic variants were identified using next-generation sequencing. Random Forest modeling with SHAP was used to quantify global and local feature contributions, while MDR was applied to detect potential non-linear gene-gene interactions beyond single-locus effects. The Random Forest model was not explicitly adjusted for familial clustering or relatedness; results were therefore interpreted as exploratory.</p><p><strong>Results: </strong>SHAP analysis identified rs1045642 (ABCB1) as the strongest contributor to model-predicted baseline thrombotic risk. MDR analysis suggested that this background susceptibility may be further modified by a two-locus interaction between rs12041331 (PEAR1) and rs1800790 (FGB). Individuals classified within the high-risk MDR genotype combination showed increased odds of thrombosis (OR = 8.00, 95% CI: 1.67-74.96; p = 0.0028), compared with the corresponding single-locus model (OR = 3.73, 95% CI: 0.93-21.48; p = 0.0405). Confidence intervals were wide, reflecting limited precision.</p><p><strong>Conclusion: </strong>In this exploratory pedigree-based study, rs1045642 (ABCB1) was associated with baseline thrombotic susceptibility, while a potential interaction between PEAR1 and FGB may further modulate risk in specific genotype combinations. The integration of MDR and SHAP provides an interpretable framework for investigating complex genetic architectures. However, given the small sample size and limited number of events, these findings should be considered hypothesis-generating and require validation in larger independent cohorts.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"609149"},"PeriodicalIF":2.1,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13570623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148956028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D Deficiency and Its Hematological Correlates in Patients with Sickle Cell Disease at a Ugandan Clinic. 乌干达一家诊所镰状细胞病患者的维生素D缺乏及其血液学相关性
IF 2.1
Journal of Blood Medicine Pub Date : 2026-09-02 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S621903
Geofrey Salamu, Elizabeth A John, Robert Wagubi, Enoch Muwanguzi, Charles Nkubi Bagenda, Benson Okongo
{"title":"Vitamin D Deficiency and Its Hematological Correlates in Patients with Sickle Cell Disease at a Ugandan Clinic.","authors":"Geofrey Salamu, Elizabeth A John, Robert Wagubi, Enoch Muwanguzi, Charles Nkubi Bagenda, Benson Okongo","doi":"10.2147/JBM.S621903","DOIUrl":"10.2147/JBM.S621903","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the prevalence of vitamin D deficiency (VDD), evaluate its correlation with key hematological parameters, and identify associated factors among patients attending the Sickle Cell Clinic at Mengo Hospital (Kampala, Uganda).</p><p><strong>Patients and methods: </strong>This cross-sectional study enrolled 213 patients with sickle cell disease (SCD) at Mengo Hospital, serum 25-hydroxyvitamin D levels were measured. Levels were classified as deficient (<20 ng/mL) or sufficient (≥20 ng/mL). Hematological indices, red blood cell (RBC) count, hemoglobin (Hb), and red cell distribution width-coefficient of variation (RDW-CV) were assessed using an automated analyzer, and Spearman correlation was used to assess correlations with vitamin D levels. Multivariable Poisson regression identified variables associated with vitamin D deficiency (VDD), reporting outcomes as adjusted prevalence ratios (aPR).</p><p><strong>Results: </strong>The median age was 10 years (IQR 5-13); 50.7% were male. The prevalence of vitamin D deficiency (VDD) was 47.4% (95% CI 40.8-54.2%). Weak but significant positive correlations were observed between serum vitamin D levels and RBC count (<i>ρ</i> = 0.170, p = 0.013) and Hb concentration (<i>ρ</i> = 0.157, p = 0.022), while a negative correlation was noted with RDW-CV (<i>ρ</i> = -0.162, p = 0.018). Adolescents and adults had a higher prevalence of VDD compared to younger children (12-17 years; aPR 1.96, p = 0.002) and (≥ 18 years; aPR 3.20, p < 0.001) respectively. Additionally, folic acid and hydroxyurea were associated with a lower risk of VDD (aPR 0.69, p = 0.028).</p><p><strong>Conclusion: </strong>Nearly half of the patients with sickle cell disease had vitamin D deficiency. Older age increased the risk. VDD is weakly but significantly associated with lower Hb/RBC and higher RDW, suggesting a possible contributory role in the hematologic profile of Ugandan SCD patients.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"621903"},"PeriodicalIF":2.1,"publicationDate":"2026-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13546668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148900549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Gray Scattergram in Detecting Blasts Compared with Microscopic Peripheral Smear in Acute Leukemia Patients. 灰色散点图与显微外周涂片检测急性白血病细胞的比较研究。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-08-31 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S589556
Novi Rostikasari, Leni Lismayanti, Adhi Kristianto Sugianli, Tiene Rostini
{"title":"Role of Gray Scattergram in Detecting Blasts Compared with Microscopic Peripheral Smear in Acute Leukemia Patients.","authors":"Novi Rostikasari, Leni Lismayanti, Adhi Kristianto Sugianli, Tiene Rostini","doi":"10.2147/JBM.S589556","DOIUrl":"10.2147/JBM.S589556","url":null,"abstract":"<p><strong>Purpose: </strong>Early and accurate diagnosis of acute leukemia is essential for timely treatment and improved patient outcomes. Gray scattergram patterns generated by hematology analyzers may indicate the presence of blasts and serve as an early screening tool. This study evaluated the correlation and agreement between gray scattergram findings and microscopic detection of blasts on peripheral blood smears in newly diagnosed acute leukemia patients.</p><p><strong>Patients and methods: </strong>This retrospective cross-sectional study used secondary data from inpatients with acute leukemia treated at Dr. Hasan Sadikin General Hospital between April 2024 and March 2025. Diagnoses were identified using ICD-10 codes for acute lymphoblastic leukemia and acute myeloid leukemia. Eligible patients had complete hematological data at diagnosis, including complete blood count and peripheral blood smear results. Collected variables included demographic characteristics, hematological parameters, peripheral blood blast percentage, analyzer-generated flags, and scattergram findings. Leukocyte differential counts and blast percentages were validated by manual microscopic examination. Scattergram findings were classified as gray or non-gray, with gray defined by the presence of ≥35.5% blasts. Agreement between gray scattergram findings and microscopic blast detection was analyzed using Cohen's kappa statistic. However, the moderate level of agreement indicates that gray scattergram findings should be interpreted cautiously and require confirmation by microscopic examination.</p><p><strong>Results: </strong>A total of 106 patients were included. Gray scattergram findings were observed in 66 patients, of whom 52 (83.9%) had ≥35.5% blasts on microscopic examination. Among non-gray scattergram cases, 10 patients (16.1%) also showed blast counts ≥35.5%. Agreement between gray scattergram findings and microscopic blast identification was moderate (κ=0.527, p<0.001).</p><p><strong>Conclusion: </strong>Gray scattergrams may provide early indications of blast presence and serve as a supportive screening tool in suspected acute leukemia. However, confirmation by peripheral blood smear or bone marrow examination remains necessary in clinical settings.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"589556"},"PeriodicalIF":2.1,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13544361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148897348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge on the Haemophilia Care Among Healthcare Providers in Tanzania: A Multicenter Cross-Sectional Study. 关于血友病护理在坦桑尼亚医疗保健提供者的知识:一个多中心横断面研究。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-08-30 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S630879
Stella Samson Rwezaula, Samson D Mtoba, Johnny Mahlangu, Amos Rodger Mwakigonja, Bolanle Iranloye, Oluyemi Akinloye
{"title":"Knowledge on the Haemophilia Care Among Healthcare Providers in Tanzania: A Multicenter Cross-Sectional Study.","authors":"Stella Samson Rwezaula, Samson D Mtoba, Johnny Mahlangu, Amos Rodger Mwakigonja, Bolanle Iranloye, Oluyemi Akinloye","doi":"10.2147/JBM.S630879","DOIUrl":"10.2147/JBM.S630879","url":null,"abstract":"<p><strong>Background: </strong>Haemophilia is a rare inherited bleeding disorder associated with recurrent bleeding, disability, and mortality when diagnosis and management are delayed. In low- and middle-income countries, limited diagnostic capacity, access to treatment and gaps in Healthcare Providers' (HCPs') knowledge are major contributors to morbidity and mortality. In Tanzania, the recent improvement in haemophilia services highlights the need for systematic evaluation of HCPs' knowledge and clinical practices.</p><p><strong>Objective: </strong>The study assessed the knowledge of haemophilia care among healthcare providers in Tanzania.</p><p><strong>Methods: </strong>A multicenter hospital-based cross-sectional study was conducted among HCPs in tertiary and regional hospitals in Tanzania. A structured self-administered questionnaire assessed knowledge on haemophilia, including the pathophysiology, clinical features, diagnosis, treatment, and complications. Data were analyzed using IBM SPSS statistics version 27.</p><p><strong>Results: </strong>Among 799 HCPs assessed (50.9%) aged 20-29 and (59.2%) males. Nurses were the majority (31.8%), and 75.2% had ≤5 years' experience. Overall haemophilia knowledge was high (median 83.3%, IQR: 75.9-88.9), strongest performance in general knowledge and weakest in treatment (68.2%, IQR: 54.5-77.3). Most respondents identified haemophilia as inherited (95.6%), non-infectious (93.7%), and recognized prolonged bleeding after injury or circumcision as key-symptoms (>90%). Knowledge varied by cadre, department, and experience (p<0.05); physicians and specialists scored higher than nurses, while health attendants scored lower.</p><p><strong>Conclusion: </strong>Healthcare providers demonstrated fairly adequate general knowledge of haemophilia. However, gaps remain in understanding genetic inheritance, acquired haemophilia, and modern treatment strategies, with knowledge variation by cadre, department, and experience, highlighting the need for targeted education across all HCPs groups.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"630879"},"PeriodicalIF":2.1,"publicationDate":"2026-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13540582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148887379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aztreonam-Avibactam Successfully Treated Severe Stenotrophomonas maltophilia Infection After Allogeneic Transplantation: A Case Report and Literature Reviews. 阿曲那南-阿维巴坦成功治疗同种异体移植后严重嗜麦芽窄养单胞菌感染1例并文献复习。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-08-29 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S618181
Honglei Wang, Jia Song, Hui Liu, Shanfeng Hao, Chongjie Pang, Rong Fu
{"title":"Aztreonam-Avibactam Successfully Treated Severe <i>Stenotrophomonas maltophilia</i> Infection After Allogeneic Transplantation: A Case Report and Literature Reviews.","authors":"Honglei Wang, Jia Song, Hui Liu, Shanfeng Hao, Chongjie Pang, Rong Fu","doi":"10.2147/JBM.S618181","DOIUrl":"10.2147/JBM.S618181","url":null,"abstract":"<p><strong>Background: </strong><i>Stenotrophomonas maltophilia</i> infection after allogeneic hematopoietic stem cell transplantation is rare and dangerous, especially bloodstream infection, with an extremely high mortality rate.</p><p><strong>Case presentation: </strong>In this study, we present a case of acute T-lymphoblastic leukemia developed St<i>enotrophomonas maltophilia</i> sepsis on the 8th day after allogeneic hematopoietic stem cell transplantation, accompanied by severe infections of the skin and soft tissues, pharynx, and gastrointestinal tract. After anti-infective treatment with aztreonam-avibactam, the patient's infection was effectively controlled. Neutrophil engraftment occurred on day 19 and platelet engraftment on day 30 post-transplantation. The patient was smoothly transferred from the transplant ward to a general ward.</p><p><strong>Conclusion: </strong>Aztreonam-avibactam may have a very good clinical effect on patients with severe and multi-site <i>Stenotrophomonas maltophilia</i> infections.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"618181"},"PeriodicalIF":2.1,"publicationDate":"2026-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13537200/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148880086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longstanding Microcytosis with a Thalassaemia-Like Phenotype and Inconclusive Molecular Testing: A Case Report. 长期小细胞病与地中海贫血样表型和不确定的分子检测:一个病例报告。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-08-28 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S627239
Fahd A Kuriri
{"title":"Longstanding Microcytosis with a Thalassaemia-Like Phenotype and Inconclusive Molecular Testing: A Case Report.","authors":"Fahd A Kuriri","doi":"10.2147/JBM.S627239","DOIUrl":"10.2147/JBM.S627239","url":null,"abstract":"<p><strong>Background: </strong>Persistent microcytosis in adults with normal or only mildly reduced haemoglobin usually prompts investigation for iron deficiency or thalassaemia trait. In some patients, however, the cause remains uncertain despite haemoglobin fractionation and targeted molecular testing.</p><p><strong>Case presentation: </strong>An asymptomatic adult male had longstanding microcytosis, with haemoglobin of 13.6 g/dL, a red blood cell count of 5.67 × 10<sup>6</sup>/µL, and a mean corpuscular volume of 72 fL. Serum iron was low, but ferritin remained within the reference range at 100.5 ng/mL. Haemoglobin fractionation showed HbA<sub>2</sub> of 2.4% and HbF below 1%, without an abnormal fraction. Multiplex PCR, sequencing of HBA2, HBA1, and HBB, and MLPA of the alpha-globin gene cluster identified no causative deletion, sequence variant, or copy-number change within the scope of testing. Rare or untested mechanisms remained possible. Empirical iron treatment was not initiated.</p><p><strong>Interpretation: </strong>The longstanding microcytosis, relatively preserved red blood cell count, normal HbA<sub>2</sub> and HbF, and preserved ferritin were consistent with a thalassaemia-like phenotype. Classical raised-HbA<sub>2</sub> beta-thalassaemia trait was considered less likely. An inherited alpha-globin abnormality or another disorder of haemoglobin synthesis remained possible, although it could not be confirmed. The preserved ferritin made absolute iron deficiency less likely, but iron-restricted erythropoiesis could not be excluded because additional iron studies were unavailable.</p><p><strong>Conclusion: </strong>This case highlights the difficulty of interpreting a stable microcytic phenotype when molecular testing does not establish a causative abnormality. Molecular findings should be considered alongside the longitudinal haematological pattern and interpreted within the analytical scope of the methods used. Iron treatment should be reserved for patients in whom iron deficiency has been demonstrated by appropriate testing.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"627239"},"PeriodicalIF":2.1,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148874278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nationwide Distribution of ABO and Rh Blood Group Phenotypes Among Mexican Outpatients: A Multicenter Retrospective Cross-Sectional Study. 墨西哥门诊患者ABO和Rh血型表型的全国分布:一项多中心回顾性横断面研究。
IF 2.1
Journal of Blood Medicine Pub Date : 2026-08-27 eCollection Date: 2026-01-01 DOI: 10.2147/JBM.S625908
José Antonio Magaña-Lizárraga, Abraham García-Gil, Diana Yadira Calva-Espinosa, Yoseli Yoruby Leal-Leyva, Ariadna Patricia Langle-Martínez, Marco Antonio Luna-Ruiz-Esparza, Abraham Campos-Romero, Jonathan Alcántar-Fernández
{"title":"Nationwide Distribution of ABO and Rh Blood Group Phenotypes Among Mexican Outpatients: A Multicenter Retrospective Cross-Sectional Study.","authors":"José Antonio Magaña-Lizárraga, Abraham García-Gil, Diana Yadira Calva-Espinosa, Yoseli Yoruby Leal-Leyva, Ariadna Patricia Langle-Martínez, Marco Antonio Luna-Ruiz-Esparza, Abraham Campos-Romero, Jonathan Alcántar-Fernández","doi":"10.2147/JBM.S625908","DOIUrl":"10.2147/JBM.S625908","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to determine the phenotypic distribution of ABO and Rh blood groups in a geographically diverse cohort of Mexican outpatients.</p><p><strong>Patients and methods: </strong>A clinic-based, retrospective, cross-sectional study was conducted using anonymized electronic health records (EHRs) from 1,820,793 individuals aged 1 to 100 years who underwent clinically or administratively indicated ABO and Rh blood typing at Salud Digna clinics across all 32 Mexican states between January 2023 and July 2025. All ABO and Rh determinations were performed by forward typing using either the fully automated Galileo Echo immunohematology analyzer or by the conventional slide method using commercial anti-A, anti-B, and anti-D antisera. Demographic and blood group distributions were summarized using descriptive statistical methods, and sex-specific distributions were evaluated.</p><p><strong>Results: </strong>Among the 1,820,793 individuals analyzed (median age: 29 years), 1,193,587 (65.6%) were female and 627,206 (34.4%) were male. Blood group O was the most frequent ABO phenotype (65.99%), whereas group AB was the least common (1.50%). For the Rh system, 3.39% of individuals exhibited the Rh(d) phenotype. The overall phenotypic distribution was as follows: O Rh(D) (64.01%), A Rh(D) (23.24%), B Rh(D) (7.92%), O Rh(d) (1.98%), AB Rh(D) (1.43%), A Rh(d) (1.02%), B Rh(d) (0.32%), and AB Rh(d) (0.07%). Notably, the AB Rh(d) phenotype was not identified in Oaxaca. From a geographical perspective, a clear north-to-south gradient was observed, with increasing frequencies of the O Rh(D) phenotype toward the southern states, accompanied by declining trends observed for the remaining ABO and Rh phenotypes.</p><p><strong>Conclusion: </strong>Blood group O was the most frequent ABO phenotype, whereas the Rh(d) phenotype was relatively uncommon. The overall distribution patterns were largely consistent across the states. These findings provide a valuable resource for health authorities and blood services to support blood inventory management, inform region-specific donor recruitment strategies for less common blood group phenotypes, and optimize planning for blood transfusion services, organ transplantation, and maternal healthcare.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"17 ","pages":"625908"},"PeriodicalIF":2.1,"publicationDate":"2026-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13528783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148865153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书